Interleukin-10 promoter single-nucleotide polymorphisms as markers for disease susceptibility and disease severity in leprosy

被引:0
作者
MO Moraes
AG Pacheco
JJM Schonkeren
PR Vanderborght
JAC Nery
AR Santos
ME Moraes
JR Moraes
THM Ottenhoff
EP Sampaio
TWJ Huizinga
EN Sarno
机构
[1] Leprosy Laboratory,Department of Tropical Medicine
[2] Oswaldo Cruz Institute,Departamento de Epidemiologia e Métodos Quantitativos em Saúde (DEMQS)
[3] FIOCRUZ,Department of Rheumatology
[4] Escola Nacional de Saúde Pública (ENSP),Department of Immunohematology and Blood Transfusion
[5] FIOCRUZ,undefined
[6] Leiden University Medical Center,undefined
[7] Laboratório de Imunogénetica,undefined
[8] Instituto Nacional do Cancer,undefined
[9] Ministério da Saúde,undefined
[10] Leiden University Medical Center,undefined
来源
Genes & Immunity | 2004年 / 5卷
关键词
interleukin-10; polymorphism; leprosy; mycobacteria;
D O I
暂无
中图分类号
学科分类号
摘要
We have determined IL-10 promoter genotypes of five single-nucleotide polymorphisms (SNPs): T−3575A, A−2849G, C−2763A, -A−1082G and C−819T. The haplotype frequencies were defined in healthy subjects compared to leprosy patients, and analyzed for their occurrence in multi- (MB) vs paucibacillary (PB) as severe and mild forms of leprosy, respectively. Haplotypes defined by three SNP positions (−3575, −2849 and −2763) captured significant differences between controls and patients (P=0.04). The haplotype carrying −3575A, −2849G and −2763C was associated with resistance to leprosy and to the development of severe forms of the disease using either a binomial (controls vs cases, P=0.005, OR=0.35, CI=0.13–0.91) or ordinal (controls vs PB vs MB, P=0.006, OR=0.32, CI=0.12–0.83) model. By contrast, the IL-10 haplotype −3575T/−2849A/−2763C was found to be associated with susceptibility to leprosy per se (P=0.027, OR=2.37, CI=1.04–5.39), but not leprosy type. The data suggest that the IL-10 locus contributes to the outcome of leprosy.
引用
收藏
页码:592 / 595
页数:3
相关论文
共 75 条
[1]  
Fine PE(1997)Household and dwelling contact as risk factors for leprosy in northern Malawi Am J Epidemiol 146 91-102
[2]  
Sterne JA(1996)Genetic epidemiology of the Mitsuda reaction in leprosy Hum Hered 46 32-35
[3]  
Ponnighaus JM(2002)Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae Nat Genet 32 97-105
[4]  
Feitosa M(2002)Genetics of susceptibility to leprosy Genes Immun 3 441-453
[5]  
Krieger H(2003)Chromosome 6q25 is linked to susceptibility to leprosy in a Vietnamese population Nat Genet 33 412-415
[6]  
Borecki I(2004)A 5-prime regulatory region shared by the PARK2 and PACRG genes controls susceptibility to leprosy Nature 427 636-640
[7]  
Beiguelman B(2004)Evidence for a cluster of genes on chromosome 17q11–q21 controlling susceptibility to tuberculosis and leprosy in Brazilians Genes Immun 5 46-57
[8]  
Rao DC(1997)Modulation of protective and pathological immunity in mycobacterial infections Int Arch Allergy Immunol 113 400-408
[9]  
Ottenhoff THM(2000)Immunological cytokine correlates of protective immunity and pathogenesis in leprosy Scand J Immunol 51 419-428
[10]  
Verreck FAW(1995)Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarized T-helper subsets: T-helper phenotype is stable and uninfluenced by related antigens of Immunology 86 97-103